Diplomat Announces 3rd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Diplomat Pharmacy (DPLO) PT Lowered to $18 at Mizuho Securities
November 8, 2018 10:49 AM ESTMizuho Securities analyst Ann Hynes lowered the price target on Diplomat Pharmacy (NYSE: DPLO) to $18.00 (from $23.00) while maintaining a Neutral rating.
Hynes commented, "We are updating our model and price target (now $18 from $23). Despite yesterday's sell-off driven by the disclosure of significant... More
Diplomat Pharmacy (DPLO) Misses Q3 EPS by 22c, Updates Guidance
November 6, 2018 4:24 PM ESTDiplomat Pharmacy (NYSE: DPLO) reported Q3 EPS of $0.00, $0.22 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.42 billion.
GUIDANCE:
Diplomat Pharmacy sees 2018 EPS of ($0.10)-$0.03, versus the consensus of $0.83. Diplomat... More
